Pat Mackin

Biography

 Mr. Pat Mackin is President and Chief Executive Officer and Chairman of CryoLife, Inc. (NYSE:CRY) (“CryoLife”) since September 2014, a leader in the manufacturing, processing, and distribution of implantable living tissues and medical devices used in cardiac surgical procedures. CryoLife markets and sells products in more than 80 countries worldwide. Before joining CryoLife, from August 2007 to July 2014, he was President of the Cardiac Rhythm Disease Management Division at Medtronic, Inc. (NYSE:MDT) (“Medtronic”). From 2004 to 2006, also at Medtronic, he held the positions of Vice President, Vascular, Western Europe where he launched the Corporation’s first drug-eluting stent called “Endeavour” and Vice President and General Manager, Endovascular Business Unit. Prior to joining Medtronic, from 1996 to 2002, Mr. Mackin worked for six years at Genzyme, Inc., serving as Senior Vice President and General Manager for the Cardiovascular Surgery Business Unit and as Director of Sales, Surgical Products division. From 1991 to 1996, Mr. Mackin spent five years at Deknatel/Snowden-Pencer, Inc. in various sales and marketing roles and three years as an Officer in the U.S. Army.

Research Interest

 Mr. Mackin received an MBA from the Kellogg School of Management at Northwestern University and is a graduate of the United States Military Academy at West Point.